We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[Effect of transplanting marrow mesenchymal stem cells via subarachnoid space on spinal cord injury and T cell subpopulation in rats].
OBJECTIVE: To investigate the therapeutic effects of transplanting allogeneic marrow mesenchymal stem cells (MSCs) via subarachnoid space on spinal cord injury(SCI) and the T cell subpopulation.
METHODS: Density gradient centrifugation was used to isolate and expand MSCs from bone marrow of 10 six-week-old SD rats. The SCI model was produced by weight-beating from 60 eight-week-old female SD rats. Forty survival SCI rats, which BBB scores were zero, were divided randomly into 2 groups:experimental group (group A) and control group (group B). In addition, 20 normal eight-week-old SI) rats were used as blank group (group C). In group A, 1 ml cells suspention containing MSCs (the 6th generation, 2 x 10(6)/ml) was injected via subarachnoid space. In group B, equal volume of L-DMEM was injected in the same way. The BBB score was obtained after 1st, 2nd and 3rd weeks of injection. At the same time,T cell subpopulation was detected by flow cytometry.
RESULTS: The BBB score in group A was better than that in group B, but fewer than that in group C in the 3rd week. CD4+ T cells in group A were less than those in groups B and C in the 1st, 2nd, and 3rd weeks. CD8+ T cells in group A were less than those in groups B and C in the 2nd and 3rd weeks. The ratio of CD4+/CD8+ T cells in group A was less than those in groups B and C in the 1st week. Above differences showed statistically significant difference (P < 0.05). However, there were no statistically significant differences in the ratio of CD4+/CD8+T cells between group A and groups B, C in the 2nd and 3rd weeks (P>0.05).
CONCLUSION: The above results suggest that allogeneic MSCs transplantation via subarachnoid space is beneficial to SCI to some extend, do not result in rejection in vivo. Furthermore, it can lead to immunosuppression in short time. So, it provides clues to apply MSCs to treat SCI and other diseases.
METHODS: Density gradient centrifugation was used to isolate and expand MSCs from bone marrow of 10 six-week-old SD rats. The SCI model was produced by weight-beating from 60 eight-week-old female SD rats. Forty survival SCI rats, which BBB scores were zero, were divided randomly into 2 groups:experimental group (group A) and control group (group B). In addition, 20 normal eight-week-old SI) rats were used as blank group (group C). In group A, 1 ml cells suspention containing MSCs (the 6th generation, 2 x 10(6)/ml) was injected via subarachnoid space. In group B, equal volume of L-DMEM was injected in the same way. The BBB score was obtained after 1st, 2nd and 3rd weeks of injection. At the same time,T cell subpopulation was detected by flow cytometry.
RESULTS: The BBB score in group A was better than that in group B, but fewer than that in group C in the 3rd week. CD4+ T cells in group A were less than those in groups B and C in the 1st, 2nd, and 3rd weeks. CD8+ T cells in group A were less than those in groups B and C in the 2nd and 3rd weeks. The ratio of CD4+/CD8+ T cells in group A was less than those in groups B and C in the 1st week. Above differences showed statistically significant difference (P < 0.05). However, there were no statistically significant differences in the ratio of CD4+/CD8+T cells between group A and groups B, C in the 2nd and 3rd weeks (P>0.05).
CONCLUSION: The above results suggest that allogeneic MSCs transplantation via subarachnoid space is beneficial to SCI to some extend, do not result in rejection in vivo. Furthermore, it can lead to immunosuppression in short time. So, it provides clues to apply MSCs to treat SCI and other diseases.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app